Does VEDOLIZUMAB Cause Product availability issue? 636 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 636 reports of Product availability issue have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.9% of all adverse event reports for VEDOLIZUMAB.
636
Reports of Product availability issue with VEDOLIZUMAB
0.9%
of all VEDOLIZUMAB reports
3
Deaths
162
Hospitalizations
How Dangerous Is Product availability issue From VEDOLIZUMAB?
Of the 636 reports, 3 (0.5%) resulted in death, 162 (25.5%) required hospitalization, and 2 (0.3%) were considered life-threatening.
Is Product availability issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 636 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Product availability issue?
RUXOLITINIB (2,142)
LISDEXAMFETAMINE DIMESYLATE (1,530)
CERTOLIZUMAB PEGOL (1,381)
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (610)
METHYLPHENIDATE (444)
SECUKINUMAB (399)
BIMEKIZUMAB-BKZX (364)
LACOSAMIDE (359)
BRIVARACETAM (324)
SACUBITRIL\VALSARTAN (283)
Which VEDOLIZUMAB Alternatives Have Lower Product availability issue Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB